Several other analysts have also recently commented on the stock. Analysts at Oppenheimer (NYSE: OPY) raised their price target on shares of Amdocs Limited from $34.00 to $36.00 in a research note to investors on Wednesday. They now have an “outperform” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Amdocs Limited in a research note to investors on Tuesday, March 13rd. They now have a $32.00 price target on the stock. Finally, analysts at Wells Fargo & Co. (NYSE: WFC) initiated coverage on shares of Amdocs Limited in a research note to investors on Monday, March 5th. They set an “outperform” rating on the stock.
Shares of Amdocs Limited traded down 0.26% during mid-day trading on Wednesday, hitting $31.14. Amdocs Limited has a 52 week low of $25.41 and a 52 week high of $32.39. The company has a market cap of $5.330 billion and a P/E ratio of 15.52.
The company last announced its quarterly results on Tuesday, May 1st. It reported $0.67 earnings per share (EPS) for the previous quarter, beating the Thomson Reuters consensus estimate of $0.64 EPS by $0.03. The company’s quarterly revenue was up 2.5% on a year-over-year basis. On average, analysts predict that Amdocs Limited will post $0.69 earnings per share next quarter.
Amdocs Limited is a provider of software and services for communications, media and entertainment industry service providers.